Effect of Sipjeondaebo-tang for Cancer Related Anorexia in Cancer Patients
Status:
Completed
Trial end date:
2016-09-01
Target enrollment:
Participant gender:
Summary
To determine efficacy and safety of Sipjeondaebo-tang for Cancer patients suffering from
anorexia after chemotherapy. Sipjeondaebo-tang will be administered for 4 weeks, 3 times per
day after a meal. Changes of FAACT scale, Anorexia VAS, Weight, BMI, Clinical laboratory test
such as ACTH, Cortisol, Chrelin, IL-6, ESR, CRP will be measured and analyzed.